# Study of NGM621 in Participants With Geographic Atrophy

> **NCT04014777** · PHASE1 · COMPLETED · sponsor: **NGM Biopharmaceuticals, Inc** · enrollment: 15 (actual)

## Conditions studied

- Geographic Atrophy

## Interventions

- **BIOLOGICAL:** NGM621
- **BIOLOGICAL:** NGM621
- **BIOLOGICAL:** NGM621
- **BIOLOGICAL:** NGM621

## Key facts

- **NCT ID:** NCT04014777
- **Lead sponsor:** NGM Biopharmaceuticals, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-26
- **Primary completion:** 2020-05-27
- **Final completion:** 2020-05-27
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2020-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04014777

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04014777, "Study of NGM621 in Participants With Geographic Atrophy". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04014777. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*